A LABILE SERUM FACTOR CLOTTING DEFECT: ITS DEMONSTRATION BY THE THROMBOPLASTIN GENERATION TEST AND ITS CLINICAL SIGNIFICANCE.
作者信息
Connor W E, Warner E D, Carter J R
机构信息
Department of Internal Medicine, State University of Iowa, College of Medicine, Iowa City, Iowa.
出版信息
J Clin Invest. 1961 Jan;40(1):13-22. doi: 10.1172/JCI104225.
Abstract
摘要
相似文献
1
A LABILE SERUM FACTOR CLOTTING DEFECT: ITS DEMONSTRATION BY THE THROMBOPLASTIN GENERATION TEST AND ITS CLINICAL SIGNIFICANCE.一种不稳定的血清因子凝血缺陷：通过凝血活酶生成试验证实及其临床意义。
J Clin Invest. 1961 Jan;40(1):13-22. doi: 10.1172/JCI104225.
2
Canine hemophilia; observations on the course, the clotting anomaly, and the effect of blood transfusions.犬血友病；关于病程、凝血异常及输血效果的观察
J Exp Med. 1949 Aug 1;90(2):97-111. doi: 10.1084/jem.90.2.97.
3
4
Anti-factor Xa assay is a superior correlate of heparin dose than activated partial thromboplastin time or activated clotting time in pediatric extracorporeal membrane oxygenation*.抗因子 Xa 测定优于活化部分凝血活酶时间或活化凝血时间，是儿科体外膜肺氧合肝素剂量的更好相关指标*。
Pediatr Crit Care Med. 2014 Feb;15(2):e72-9. doi: 10.1097/PCC.0000000000000028.
5
Activated partial thromboplastin time is a better trending tool in pediatric extracorporeal membrane oxygenation.活化部分凝血活酶时间是小儿体外膜肺氧合中更好的趋势工具。
Pediatr Crit Care Med. 2012 Nov;13(6):e363-71. doi: 10.1097/PCC.0b013e31825b582e.
6
The possible relationship between the antiheparin activity of serum and thrombosis.血清抗肝素活性与血栓形成之间的可能关系。
J Clin Pathol. 1960 May;13(3):226-9. doi: 10.1136/jcp.13.3.226.
7
Importance of factor-IX-dependent prothrombinase formation--the Josso pathway--in clotting plasma.
Haemostasis. 1989;19(6):301-8. doi: 10.1159/000216034.
8
9
The role of factor IX in tissue thromboplastin induced coagulation.凝血因子IX在组织凝血活酶诱导凝血中的作用。
Thromb Haemost. 1982 Aug 24;48(1):54-8.
引用本文的文献
1
THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR THE PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR.镧系元素和锕系元素对血液凝固的影响。I. 一种新的血清凝血活酶因子特性的证据。
J Clin Invest. 1964 Apr;43(4):705-19. doi: 10.1172/JCI104955.
2
THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. II. ASSAY OF A NEW SERUM THROMBOPLASTIC FACTOR VULNERABLE TO THESE ELEMENTS AND ITS VARIATIONS IN HEALTH AND DISEASE.镧系元素和锕系元素对血液凝固的影响。II. 一种对这些元素敏感的新型血清凝血因子的测定及其在健康和疾病中的变化
J Clin Invest. 1964 Apr;43(4):720-7. doi: 10.1172/JCI104956.
本文引用的文献
1
Fundamental interactions and effect of storage, ether, adsorbants and blood clotting on plasma antithrombin activity.储存、乙醚、吸附剂及血液凝固对血浆抗凝血酶活性的基本相互作用及影响
Am J Physiol. 1952 Jun;169(3):700-11. doi: 10.1152/ajplegacy.1952.169.3.700.
2
Autocatalytic formation of thrombin in blood coagulation.血液凝固中凝血酶的自催化形成。
Acta Med Scand. 1951;140(4):290-306. doi: 10.1111/j.0954-6820.1951.tb10180.x.
3
SPAET TH: Thromboplastin generation as a test of liver function.
Am J Med Sci. 1959 Sep;238:280-6. doi: 10.1097/00000441-195909000-00003.
4
Evidence for a new serum thromboplastic factor.一种新的血清凝血致活酶因子的证据。
Thromb Diath Haemorrh Suppl. 1960;4:66-85.
5
Activation of prothrombin with thrombin.凝血酶对凝血酶原的激活作用。
Am J Physiol. 1958 Aug;194(2):280-4. doi: 10.1152/ajplegacy.1958.194.2.280.
6
Influence of soybean phosphatide on blood coagulation and its use in the thromboplastin generation test.大豆磷脂对血液凝固的影响及其在凝血活酶生成试验中的应用。
Proc Soc Exp Biol Med. 1958 Jan;97(1):38-43. doi: 10.3181/00379727-97-23640.
7
Some factors that influence utilization of antihemophilic activity during clotting.一些在凝血过程中影响抗血友病活性利用的因素。
Proc Soc Exp Biol Med. 1957 Nov;96(2):277-81. doi: 10.3181/00379727-96-23454.
8
Blood coagulation with particular reference to the early stages.血液凝固，尤其涉及早期阶段。
Physiol Rev. 1956 Oct;36(4):479-502. doi: 10.1152/physrev.1956.36.4.479.
9
Studies on the thromboplastin generation test. II. Basic mechanisms and theoretical aspects.凝血活酶生成试验研究。II. 基本机制及理论方面。
Am J Clin Pathol. 1956 Sep;26(9):984-97. doi: 10.1093/ajcp/26.9.984.
10
An action of thrombin on platelets in accelerating clotting.凝血酶对血小板在加速凝血方面的作用。
Blood. 1954 Feb;9(2):153-62.
Zotero 插件